Matthew P. Ottmer
Keine laufenden Positionen mehr
Karriereverlauf von Matthew P. Ottmer
Ehemalige bekannte Positionen von Matthew P. Ottmer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VOYAGER THERAPEUTICS, INC. | Geschäftsführer | 18.09.2017 | 12.02.2020 |
MOMENTA PHARMACEUTICALS, INC. | Geschäftsführer | 07.12.2015 | 01.04.2017 |
BIOGEN INC. | Corporate Officer/Principal | 01.01.1999 | 01.07.2015 |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Präsident | - | - |
Ausbildung von Matthew P. Ottmer
University of Michigan | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Chief Operating Officer | 2 |
President | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VOYAGER THERAPEUTICS, INC. | Health Technology |
BIOGEN INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Matthew P. Ottmer
- Erfahrung